scispace - formally typeset
B

Brian F. O'Dowd

Researcher at Centre for Addiction and Mental Health

Publications -  149
Citations -  18243

Brian F. O'Dowd is an academic researcher from Centre for Addiction and Mental Health. The author has contributed to research in topics: Receptor & G protein-coupled receptor. The author has an hindex of 74, co-authored 149 publications receiving 17540 citations. Previous affiliations of Brian F. O'Dowd include University of Toronto.

Papers
More filters
Journal ArticleDOI

Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1

TL;DR: The cloning of a gene encoding a 477-amino-acid protein with strong homology to the cloned Dt receptor is reported here the existence of a dopamine D1-like receptor with these characteristics had not been predicted and may represent an alternative pathway for dopamine-mediated events and regulation of D2 receptor activity.
Journal ArticleDOI

A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11

TL;DR: PCR analysis of somatic cell lines found APJ-related sequences to be only present on chromosome 11, and high-resolution mapping by fluorescence in situ hybridization (FISH) sublocalized APJ on band q12.
Journal ArticleDOI

Characterization of the human cysteinyl leukotriene 2 receptor.

TL;DR: The cloning and characterization of the second cysteinyl leukotriene receptor, CysLT2, a 346-amino acid protein with 38% amino acid identity to the Cys LT1 receptor is described and demonstrated high affinity binding and a rank order of potency for competition of LTC4 = LTD4 ≫ LTE4.
Journal ArticleDOI

Characterization of Apelin, the Ligand for the APJ Receptor

TL;DR: Both sequence and mRNA expression distribution analyses revealed similarities between apelin and angiotensin II, suggesting they that share related physiological roles.
Journal ArticleDOI

Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties.

TL;DR: Evidence is provided for the direct interaction of mu- and delta-opioid receptors to form oligomers, with the generation of novel pharmacology and G protein coupling properties.